title: A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
abstract: Cytotoxic T lymphocytes (CTL) play a critical role in controlling human immunodeficiency virus-1 (HIV-1) and simian immunodeficiency virus (SIV) infections. However, in spite of developing a strong CTL response most HIV-1-infected patients eventually progress to AIDS. Amino acid changes in CTL epitope have been previously described and may permit HIV to escape from CTL immune responses. The importance of CTL selection pressure in controlling the course of viral evolution in HIV-infected patient remains debatable. For over a 10-year period, we longitudinally followed a patient for bulk unstimulated effector (eCTL) and stimulated memory CTL responses (mCTL) against the viral proteins Gag, Pol, and Nef. The patient showed a strong CTL response against Nef in unstimulated peripheral blood mononuclear cells with a peak during Month 40 of the follow-up. The mCTL response was also higher against Nef than Gag and Pol. PCR amplification and nucleotide sequencing of the plasma viral variants showed a viral variant with the epitope deletion that was detected early during the follow-up and essentially replaced the wild-type virus during the peak eCTL response. These studies support the importance of Nef epitope deletion as a mechanism for HIV-1 escape from CTL immune pressure.
authors.affiliation: Laboratoire d'Immunopathologie Virale, URA CNRS 1930, Institut Pasteur, 75015 Paris, France.
authors.forename: M K
authors.initials: MK
authors.lastname: Singh
authors.forename: G
authors.initials: G
authors.lastname: Janvier
authors.forename: V
authors.initials: V
authors.lastname: Calvez
authors.forename: P
authors.initials: P
authors.lastname: Coulaud
authors.forename: Y
authors.initials: Y
authors.lastname: Rivière
mesh_terms: D000595:Amino Acid Sequence; D018791:CD4 Lymphocyte Count; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D005500:Follow-Up Studies; D015693:Gene Products, nef / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D014644:Genetic Variation / Q000235:genetics; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D012367:RNA, Viral / Q000097:blood; D017384:Sequence Deletion / Q000235:genetics*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019562:Viral Load; D054311:nef Gene Products, Human Immunodeficiency Virus
chemical_list: D018984:Epitopes, T-Lymphocyte; D015693:Gene Products, nef; D015488:HIV Antigens; D012367:RNA, Viral; D054311:nef Gene Products, Human Immunodeficiency Virus